Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Respiratory Distress Syndrome, Adult D012128 15 associated lipids
Epilepsy D004827 35 associated lipids
Seizures D012640 87 associated lipids
Nerve Degeneration D009410 53 associated lipids
Birth Weight D001724 23 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Hypertension D006973 115 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Cerebrovascular Disorders D002561 25 associated lipids
Nasal Polyps D009298 26 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Lie WJ et al. Degranulation of human basophils by picomolar concentrations of IL-3, IL-5, or granulocyte-macrophage colony-stimulating factor. 1998 J. Allergy Clin. Immunol. pmid:9600507
Yamada M et al. Inhibition of tumor necrosis factor-alpha production by SK&F 98625, a CoA-independent transacylase inhibitor, in cultured rat peritoneal macrophages. 1998 Life Sci. pmid:9600332
Wang F et al. [The effect of platelet activating factor on the biosynthesis of thromboxane A2 and prostaglandin I2 in human placental villi and umbilical artery]. 1997 Zhonghua Fu Chan Ke Za Zhi pmid:9596897
Colak O et al. The effect of Ginkgo biloba on the activity of catalase and lipid peroxidation in experimental strangulation ileus. 1998 Int. J. Clin. Lab. Res. pmid:9594365
Jackson JR et al. The role of platelet activating factor and other lipid mediators in inflammatory angiogenesis. 1998 Biochim. Biophys. Acta pmid:9593866
Pietsch P et al. Effects of platelet-activating factor on intracellular Ca2+ concentration and contractility in isolated cardiomyocytes. 1998 J. Cardiovasc. Pharmacol. pmid:9593076
Takasaki J et al. Synergistic effect of type II phospholipase A2 and platelet-activating factor on Mac-1 surface expression and exocytosis of gelatinase granules in human neutrophils: evidence for the 5-lipoxygenase-dependent mechanism. 1998 J. Immunol. pmid:9590257
Hüseyinov A et al. Plasma and urinary platelet activating factor concentrations and leukotriene releasing activity of leukocytes in steroid sensitive nephrotic syndrome of childhood. 1998 Acta Paediatr Jpn pmid:9583202
Ereth MH et al. The relation between the platelet-activated clotting test (HemoSTATUS) and blood loss after cardiopulmonary bypass. 1998 Anesthesiology pmid:9579505
Shindo K and Fukumura M Oxatomide inhibits synthesis and release of platelet-activating factor in human neutrophils. 1998 Prostaglandins Leukot. Essent. Fatty Acids pmid:9578146
Kitayama J et al. The C-C chemokine receptor CCR3 participates in stimulation of eosinophil arrest on inflammatory endothelium in shear flow. 1998 J. Clin. Invest. pmid:9576767
Thijs A and Thijs LG Pathogenesis of renal failure in sepsis. 1998 Kidney Int. Suppl. pmid:9573570
Cines DB et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. 1998 Blood pmid:9572988
Snapper JR et al. Effect of platelet-activating factor-receptor antagonism on endotoxin-induced lung dysfunction in sheep. 1998 J. Appl. Physiol. pmid:9572806
Ruiz-Ortega M et al. Overexpression of extracellular matrix proteins in renal tubulointerstitial cells by platelet-activating-factor stimulation. 1998 Nephrol. Dial. Transplant. pmid:9568845
Ezeamuzie CI et al. The effect of salmeterol on human eosinophils is both stimulus- and response-dependent. 1997 Int. J. Immunopharmacol. pmid:9568547
Brunet J et al. In vitro antioxidant properties of calcium dobesilate. 1998 Fundam Clin Pharmacol pmid:9565776
da Silva MB et al. Effect of ketoprofen on PAF-induced bovine platelet aggregation. 1998 Vet. J. pmid:9564275
Akiyama M et al. Identification of a major PAF acetylhydrolase in human serum/plasma as a 43 kDa glycoprotein containing about 9 kDa asparagine-conjugated sugar chain(s). 1998 J. Biochem. pmid:9562606
Wei Y et al. Structure of a microbial homologue of mammalian platelet-activating factor acetylhydrolases: Streptomyces exfoliatus lipase at 1.9 A resolution. 1998 Structure pmid:9562561